Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen
出版年份 2023 全文链接
标题
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen
作者
关键词
-
出版物
Journal of Neuroimmune Pharmacology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-31
DOI
10.1007/s11481-023-10086-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dementias Among Older Males and Females in the U.S. Medicare System With and Without HIV
- (2023) Xiaoying Yu et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders
- (2022) A. Barco et al. JOURNAL OF NEUROVIROLOGY
- Patterns of Cerebrospinal Fluid Alzheimer’s Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition
- (2022) Mattia Trunfio et al. Viruses-Basel
- Impact of HIV-associated cognitive impairment on functional independence, frailty and quality of life in the modern era: a meta-analysis
- (2022) Martins Nweke et al. Scientific Reports
- Quality of life in people living with HIV-associated neurocognitive disorder: A scoping review study
- (2021) Kate Alford et al. PLoS One
- HIV and risk of dementia in older veterans
- (2020) Kirsten Bobrow et al. AIDS
- Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV
- (2020) Mattia Trunfio et al. AIDS
- A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs
- (2020) Ilaria De Benedetto et al. JOURNAL OF NEUROVIROLOGY
- Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT alone
- (2020) Daniel Bradshaw et al. BMJ Open
- Comparison of dementia risk after age 50 between individuals with and without HIV infection
- (2020) Jennifer O. Lam et al. AIDS
- Maraviroc intensification modulates atherosclerotic progression in HIV suppressed patients at high cardiovascular risk. A randomized, cross-over, pilot study
- (2019) Daniela Francisci et al. Open Forum Infectious Diseases
- Plasma and CSF neurofilament light
- (2019) Michelle M. Mielke et al. NEUROLOGY
- HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression?
- (2019) Alessandra Bandera et al. Frontiers in Aging Neuroscience
- The effect of HIV infection, antiretroviral therapy on carotid intima-media thickness: A systematic review and meta-analysis
- (2019) Titus F. Msoka et al. LIFE SCIENCES
- How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well‐treated HIV‐positive population?
- (2019) M Metral et al. HIV MEDICINE
- Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders
- (2018) M Trunfio et al. HIV MEDICINE
- Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial
- (2018) Ignacio Pérez-Valero et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose
- (2018) Andrea Calcagno et al. Current HIV/AIDS Reports
- Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy
- (2018) Albert M. Anderson et al. JOURNAL OF NEUROVIROLOGY
- CSF extracellular vesicles and neurofilament light protein as biomarkers of CNS injury in HIV-infected patients on antiretroviral therapy
- (2018) Debjani Guha et al. AIDS
- Diagnostic accuracy of noninvasive markers of steatosis, NASH and liver fibrosis in HIV-monoinfected individuals at-risk of non-alcoholic fatty liver disease (NAFLD)
- (2018) Maud Lemoine et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial
- (2017) Ned Sacktor et al. JOURNAL OF NEUROVIROLOGY
- Macrophage functions in lean and obese adipose tissue
- (2017) Dylan Thomas et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder
- (2016) Thomas M. Gates et al. AIDS
- Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C
- (2016) Victor G. Valcour et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study
- (2016) Edward R. Hammond et al. JOURNAL OF NEUROVIROLOGY
- A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication
- (2016) Matteo Vassallo et al. JOURNAL OF NEUROVIROLOGY
- CCR5 blockade for neuroinflammatory diseases — beyond control of HIV
- (2016) Guillaume Martin-Blondel et al. Nature Reviews Neurology
- Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
- (2016) Arvid Edén et al. PLoS One
- Maraviroc Reduces Arterial Stiffness in PI-Treated HIV-infected Patients
- (2016) Stefania Piconi et al. Scientific Reports
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?
- (2015) Jonathan Underwood et al. AIDS
- Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study
- (2015) A. Mondi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients
- (2015) A. Calcagno et al. JOURNAL OF NEUROVIROLOGY
- Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction
- (2014) Anna Mietelska-Porowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)
- (2014) Lishomwa C. Ndhlovu et al. JOURNAL OF NEUROVIROLOGY
- Controversies in HIV-associated neurocognitive disorders
- (2014) Sam Nightingale et al. LANCET NEUROLOGY
- The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients
- (2014) Enrique Ortega Gonzalez et al. Journal of the International AIDS Society
- Liver fibrosis is associated with cognitive impairment in HIV-positive patients
- (2014) Nicoletta Ciccarelli et al. Journal of the International AIDS Society
- Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques
- (2013) Kathleen M. Kelly et al. AIDS
- Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study
- (2013) Matteo Vassallo et al. JOURNAL OF NEUROVIROLOGY
- Abnormal Liver Stiffness Assessed Using Transient Elastography (Fibroscan®) in HIV-Infected Patients without HBV/HCV Coinfection Receiving Combined Antiretroviral Treatment
- (2013) Sang Hoon Han et al. PLoS One
- Alterations in Cerebrospinal Fluid Chemokines Are Associated With Maraviroc Exposure and In Vivo Metabolites Measurable by Magnetic Resonance Spectroscopy
- (2012) Jaime H. Vera et al. HIV CLINICAL TRIALS
- Antiretroviral neurotoxicity
- (2012) Kevin Robertson et al. JOURNAL OF NEUROVIROLOGY
- CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite study
- (2011) L. Garvey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
- (2011) N. Ciccarelli et al. NEUROLOGY
- Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy
- (2010) Aylin Yilmaz et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Serum Levels of the Immune Activation Marker Neopterin Change With Age and Gender and Are Modified by Race, BMI, and Percentage of Body Fat
- (2010) M. E. Spencer et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started